БИОМЕДИЦИНСКИЙ ЖУРНАЛ МЕДЛАЙН.РУ
Содержание журнала

Архив

Редакция
Учредители

Федеральное государственное бюджетное учреждение «Научно-клинический центр токсикологии имени академика С.Н. Голикова Федерального медико-биологического агентства»


Федеральное государственное бюджетное учреждение науки
Институт теоретической и экспериментальной биофизики
Российской академии наук


ООО "ИЦ КОМКОН"

Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314


Клиническая медицина » Хирургия • Онкология

Том: 8
Статья: « 26 »
Страницы:. 268-282
Опубликована в журнале: 0 г.

English version

Молекулярно-цитогенетическая диагностика рака мочевого пузыря

Слозина Н.М., Никифоров А.М., Неронова Е.Г., Горелов С.И., Пулин И.Л.

ФГУЗ Всероссийский центр экстренной и радиационной медицины МЧС России,
лаборатория биодозиметрии и клинической цитогенетики, г.Санкт-Петербург.
Центральная медико-санитарная часть 122 МЗ РФ отделение урологии г.Санкт-Петербург.
Ленинградский Областной Онкологический Диспансер, отделение онкоурологии.


Резюме



Ключевые слова




(статья в формате PDF. Для просмотра необходим Adobe Acrobat Reader)



открыть статью в новом окне

Список литературы

1. Bubendorf L., Grilli B., Sauter G., Mihatsch M.J., Gasser T.C., Dalquen P. Multiprobe FISH


for enhanced detection of bladder cancer in voided urine specimens and bladder washings. //


Am. J. Clin. Pathol. - 2001. - V.116, N.1. - P.79-86.


2. Maier U., Simak R., Neuhold N. The clinical value of urinary cytology: 12 years of experience


with 615 patients. // J. Clin. Pathol. - 1995. - V.48. - P.314-317.


3. Main C., Pycha A., Wiener H., et al. Immunocyt: a new tool for detecting transitional cell


cancer of the urinary tract. // J Urol. - 1999. - V.161. - P.1486-1489.


4. Ross J.S., Cohen M.B. Ancillary methods for the detection of recurrent urothelial neoplasma.


// Cancer. - 2000. - V.90. - P.75-86.


5. Glas A.S., Roos D., Deutekom M., Zwinderman A.H., Bossuyt P.M.M., Kurth K.H. Tumor


markers in the diagnosis of primary bladder cancer. A systematic review. // The Journal of


Urology. - 2003. - V.169. - P.1975-1982


6. Amiel G.E., Shu T., Lerner S.P. Alternatives to cytology in the management of non-muscle


invasive bladder cancer. // Curr. Treat. Options. Oncol. - 2004. - V.5, N.5. - P.377-389.


7. Аль-Шукри С.Х., Корнеев И.А. Общие принципы лечения больных раком мочевого


пузыря. Значение клинических, гистологических и биологических факторов прогноза для


выбора метода лечения. // Практическая онкология. - 2003. - V.4, N.4. - P.204-213.


8. Mudle S.D., Sokolova I. Clinical implications of advanced molecular cytogenetics in cancer. //


Expert Rev. Mol. Diagn. - 2004. - V.4, N.1. - P. 71-81.


9. Sandberg A.A., Berger C.S. Review of chromosome studies in urological tumors. II.


Cytogenetics and molecular genetics of bladder cancer. // J Urol. - 1994. - V.151. - P.545-560.


Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and


bladder washings. // Am. J. Clin. Pathol. - 2001. - V.116, N.1. - P.79-86.


10. Sidransky D., Messing E. Molecular genetics and biochemical mechanisms in bladder


cancer. Oncogenes, tumor suppressor genes, and growth factors (review). // Urol. Clin. N. Am. -


1992. - V.19. - P.629-639.


11. Knowles M.A. Molecular genetics of bladder cancer (review). // Br J Urol - 1995. - V.75. -


P.57-66.


12. Имянитов Е.Н., Хансон К.П. Эпидемиология и биология рака мочевого пузыря. //


Практическая онкология. - 2003. - Т.4, N.4. - C.191-195.


13. Bartlett J.M., Adie L., Watters A.D., Going J.J., Grigor K.M. Chromosomal aberrations in


transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy.


// BJU Int. - 1999. - V.84, N.7. - P.775-779


14. Santos L., Pereira S., Leite R.P., Souto M., Amaro T., Criado B. Chromosome instability and


progression in urothelial cell carcinoma of the bladder.// B. Acta Oncol. - 2003. - V.42, N.2. -


P.169-173.


15. Cairns P., Shaw M.E., Knowles M.A. Initiation of bladder cancer may involve deletion of a


tumour-suppressor gene on chromosome 9. // Oncogene. - 1993. - V. 8. - P.1083-1085.


16. Spruck C.H., Ohneseit P.F., Gonzalez-Zulueta M., Esrig D., Miyao N., Tsai Y.C., Lerner


S.P., Schmutte C., Yang A.S., Cote R. Two molecular pathways to transitional cell carcinoma of


the bladder. // Cancer Res. - 1994. - V.54. - P.784-788.


17. Rosin M.P., Cairns P., Epstein J.I., Schoenberg M.P., Sidransky D. Partial allelotype of


carcinoma in situ of the human bladder. // Cancer Res. - 1995. - V.55. - P.5213-5216.


18. Ruppert J.M., Tokino K., Sidransky D. Evidence for two bladder cancer suppressor loci on


human chromosome 9. // Cancer Res. - 1993. - V.53. - P.5093-5095.


19. Balazs M., Carroll P., Kerschmann R., Sauter G., Waldman F.M. Frequent homozygous


deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer


detected by fluorescence in situ hybridization. // Genes Chromosomes Cancer. - 1997. - V.19. -


P.84-89.


20. Orlow I., Lacombe L., Hannon G.J., Serrano M., Pellicer I., Dalbagni G., Reuter V.E., Zhang


Z.F., Beach D., Cordon-Cardo C. Deletion of the p16 and p15 genes in human bladder tumors. //


J Natl Cancer Inst. - 1995. - V.87. - P.1524-1529.


21. Richter J., Jiang F., Gorog J.P., Sartorius G., Egenter C., Gasser T.C., Moch H., Mihatsch


M.J., Sauter G. Marked genetic differences between stage pTa and stage pT1 papillary bladder


cancer detected by comparative genomic hybridization. // Cancer Res - 1997. - V.57. - P.2860-


2864.


22. Sasaki K., Hamano K., Kinjo M., Hara S. Intratumoral heterogeneity in DNA ploidy of


bladder carcinomas. // Oncology. - 1992. - V.49. - P.219-222.


23. Shackney S.E., Berg G., Simon S.R., Cohen J., Amina S., Pommersheim W., Yakulis R.,


Wang S., Uhl M., Smith C.A. Origins and clinical implications of aneuploidy in early bladder


cancer. // Cytometry - 1995. - V.22. - P.307-316.


24. Billerey C., Lamy B., Bittard H., Rozan S., Carbillet J.P. Flow cytometry versus urinary


cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.


// World J Urol. - 1993. - V. 11. - P.156-160.


25. Zhao J., Richter J., Wagner U., Roth B., Schraml P., Zellweger T., Ackerman D., Schmid U.,


Moch H., Mihatsch M.J., Gasser T.C., Sauter G. Chromosomal imbalances in noninvasive


papillary bladder neoplasms (pTa). // Cancer Res. - 1999. - V.59. - P.4658-4661.


26. Zhang F.F., Arber D.A., Wilson T.G., Kawachi M.H., Slovak M.L. Toward the validation of


aneusomy detection by hybridizatio in situ hybridization in bladder cancer: comparative anlalysis


with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing


limitations. // Clin Cancer Res - 1997. - V.3. - P.2317-2328.


27. Wheeless L.L., Reeder J.E., Han R., O?Connell M.J., Frank I.N., Cockett A.T., Hopman A.H.


Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. //


Cytometry. - 1994. - V.17. - P.319-326.


28. Ramaekers F.C., Hopman A.H. Detection of genetic aberrations in bladder cancer using in


situ hybridization. // Ann NY Acad Sci - 1993. - V.677. - P.199-213.


29. Meloni A.M., Peier A.M., Haddad F.S., Powell I.J., Block A.W., Huben R.P., Todd I., Potter


W., Sandberg A.A. A new approach in the diagnosis and follow-up of bladder cancer. FISH


analysis of urine, bladder washings, and tumors. // Cancer. Genet. Cytogenet. - 1993. - V.71. -


P.105-118.


30. Pycha A., Mian C., Haitel A., Hofbauer J., Wiener H., Marberger M. Fluorescence in situ


hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder


cancer. // J Urol. - 1997. - V.157. - P.2116-2119.


31. Cajulis R.S., Haines G.K., Frias-Hidvegi D., McVary K. Interphase cytogenetics as an


adjunct in the cytodiagnosis of urinary bladder carcinoma: a comparative study of cytology, flow


cytometry and interphase cytogenetics in bladder washes. // Anal. Quant. Cytol. Histol. - 1994. -


V.16. - P.1-10.


32. Cajulis R.S., Haines G.K., Frias-Hidvegi D., McVary K., Bacus J.W. Cytology, flow


cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in


the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. // Diag.


Cytopathol. - 1995. - V.13. - P.214-223


33. Sokolova I.A., Halling K.C., Jenkins R.B., Burkhardt H.M., Meyer R.G., Seelig S.A., King


W. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the


detection of urothelial carcinoma in urine. // J. Mol. Diagn. - 2000. - V.2, N.3. - P.116-123.


34. Cianciulli A.M., Bovani R., Leonardo F., Antenucci A., Gandolfo G.M., Giannarelli D.,


Leonardo C., Iori F., Laurenti C. Interphase cytogenetics of bladder cancer progression:


relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome. // Int


J Clin. Lab. Res. - 2000. - V.30, N.1. - P.5-11.


35. Halling K.C., King W., Sokolova I.A. et al. A comparison of cytology and fluorescence in


situ hybridization for the detection of bladder cancer. // J. Urol. - 2000. - V.164. - P.1768-1775.


36. Halling K.C., King W., Sokolova I.A., Karnes R.J., Meyer R.G., Powell E.L., Sebo T.J.,


Cheville J.C., Clayton A.C., Krajnik K.L., Ebert T.A., Nelson R.E., Burkhardt H.M.,Ramakumar S., Stewart C.S., Pankratz V.S., Lieber M.M., Blute M.L., Zincke H., Seelig S.A.,


Jenkins R.B., O?Kane D.J. A comparison of BTA stat, hemoglobin dipstick, telomerase and


Vysis UroVysion assays for the detection of urothelial carcinoma in urine. // J Urol. - 2002. - V.


167, N.5. - P.2001-2006.


37. Sarosdy M.F., Schellhammer P., Bokinsky G., Kahn P., Chao R., Yore L., Zadra J., Burzon


D., Osher G., Bridge J.A., Anderson S., Johansson S.L., Lieber M., Soloway M., Flom K.


Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of


bladder cancer. // J Urol. - 2002. - V. 168, N.5. - P.1950-1954.


38. Quek M.L., Sanderson K., Daneshmand S., Stein J.P. New molecular markers for bladder


cancer detection. // Curr. Opin. Urol. - 2004. - V. 14, N.5. - P.259-264.


39. Mezzelani A., Dagrada G., Alasio L., Sozzi G., Pilotti S. Detection of bladder cancer by


multitarget multicolour FISH: comparative analysis on archival cytology and paraffin-embedded


tissue. // Cytopathology. - 2002. - V.13, N.5. - P.317-325.


40. Mian C., Lodde M., Comploj E., Negri G., Egarter-Vigl E., Lusuardi L., Palermo S.,


Marberger M., Pycha A. Liquid-based cytology as a tool for the performance of uCyt+ and


Urovysion Multicolour-FISH in the detection of urothelial carcinoma. // Cytopathology - 2003. -


V.14, N.6. - P.338-342.


41. Droller M.J. Bladder cancer: state-of-the art care. // CA Cancer J. Clin. - 1998. - V.48, N.5. -


P.269-284.


42. Laudadio J., Keane T.E., Reeves H.M., Savage S.J., Hoda R.S., Lage J.M., Wolff D.J.


Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for


clinical practice. // BJU Int. - 2005. - V.96, N.9. - P.1280-1285.


43. Daniely M., Rona R., Kaplan T., Olsfanger S., Elboim L., Zilberstien Y., Friberger A.,


Kidron D., Kaplan E., Lew S., Leibovitch I. Combined analysis of morphology and fluorescence


in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine


samples. // Urology. - 2005. - V.66, N.6. - P.1354-1359.


44. Lubbe L., Nowack R., May M., Ullmann K., Gunia S., Kaufmann O., Hakenberg O., Muche


J., Hoschke B. FISH-a new noninvasive method for the diagnosis of urinary bladder carcinomas.


// Clin. Lab. - 2004. - V.50, N.7-8. - P.395-402.


45. Halling K.C. Vysis UroVysion for the detection of urothelial carcinoma. // Expert Rev Mol


Diagn. - 2003. - V.3, N.4. - P.507-519.


46. Pycha A., Lodde M., Comploj E., Negri G., Egarter-Vigl E., Vittadello F., Lusuardi L.,


Palermo S., Mian C. Intermediate-risk urothelial carcinoma: an unresolved problem? // Urology.


- 2004. - V.63, N.3. - P.472-475.


WWW.MEDLINE.RU ТОМ 8, ОНКОЛОГИЯ, МАЙ 2007


Дата поступления: 11.04.2007.


47. Kruger S., Mess F., Bohle A., Feller A.C. Numerical aberrations of chromosome 17 and the


9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell


carcinoma of the urinary bladder. // Int J Oncol. - 2003. - V.23, N.1. - P.41-48.


48. Bollmann M., Heller H., Bankfalvi A., Griefingholt H., Bollmann R. Quantitative molecular


urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients


with superficial bladder cancer? // BJU Int. - 2005. - V.95, N.9. - P.1219-1225.


49. Mian C, Lodde M, Comploj E, Lusuardi L, Palermo S, Mian M, Maier K, Pycha A.


Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder


cancer. // J Clin Pathol. - 2006 - V.59 - P. 984-987.


50. Veeramachaneni R., Nordberg M.L., Shi R., Herrera G.A., Turbat-Herrera E.A. Evaluation


of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing


urothelial carcinoma. // Diagn. Cytopathol. - 2003. - V.28, N.6. - P.301-307.


51. Skacel M., Fahmy M., Brainard J.A., Pettay J.D., Biscotti C.V., Liou L.S., Procop G.W.,


Jones J.S., Ulchaker J., Zippe C.D., Tubbs R.R. Multitarget fluorescence in situ hybridization


assay detects transitional cell carcinoma in the majority of patients with bladder cancer and


atypical or negative urine cytology. // J Urol. - 2003. - V.169, N.6. - P.2101-2105.


52. Varella-Garcia M., Akduman B., Sunpaweravong P., Di Maria M.V., Crawford E.D. The


UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence


of bladder cancer. // Urol Oncol. - 2004. - V.22, N.1. - P.16-19.